Purchase Order HHSN272201600780P
Award Date 6/13/16
Potential Completion Date 6/20/16
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burien, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the delivery of EasySep Enrichment Kits, which are specialized cell separation products used in biomedical research, particularly for studies in areas like stem cell research, immunology, cancer, and infectious diseases. The...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of the "EasySep Negative Human NK, 1 mL" product, which is a cell separation system used in stem cell research, immunology, and infectious...
- This is a firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the provision of the EasySep Human Pan-B Cell Enrichment Kit, a specialized cell separation product used to support biomedical research initiatives. The contract has a ceiling value of...
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $100,836.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit company, to provide EASYSEP ENRICHMENT KITS. This contract has a performance period from July 5, 2017 to July 5, 2018 and was not set aside for a particular type of small business. Stemcell Technologies Inc. is an established federal contractor...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, valued at $5,636.00, is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research. Stemcell Technologies Inc....
- Stemcell Technologies Inc. received a $18,916.80 firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) on September 1, 2021, for EasySep Human Kits with an ultimate completion date of July 1, 2022. The contract was issued without a small business set-aside designation. The procurement was structured as an administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with closure...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Stemcell Technologies Inc., a Canadian-owned for-profit organization, on August 6, 2019. The $24,069.90 contract is for the delivery of EasySep Negative Human CD4 Kits and EasySep Negative Human CD8 Kits, which are specialized biological products used in life sciences research. This sole-source award was made under the authority of 41 U.S.C....
- This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...
- This is a federal purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, valued at $23,828.70, is for the delivery of REAGENT MATERIALS - EASYSEP HUMAN IMMUNE CELL ISOLATION KITS by the prime contractor, Stemcell Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is a firm fixed-price purchase order with an ultimate...